Market Movers: Blueprint Medicines (BPMC) Jumps 8.41% to Close at $64.72 August 4

Equities Staff  |

Blueprint Medicines Corp (NASDAQ:BPMC) stock was among today's market movers, ending trading up 8.41% to $64.72 on August 4.

778,696 shares traded hands in comparison to the 30-day daily average of 656,295 shares.

The company's stock has climbed 44.26% so far in 2022.

Blueprint Medicines shares have traded in a range between $43.46 and $117.86 over the past twelve months.

The company expects its next earnings on 2022-10-27.

For technical charts, analysis, and more on Blueprint Medicines visit the company profile.

About Blueprint Medicines Corp

Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, the company creates therapies that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, Blueprint has leveraged its research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, the company is delivering its approved medicines to patients in the United States and Europe, and the company is globally advancing multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy.

To get more information on Blueprint Medicines Corp and to follow the company's latest updates, you can visit the company's profile page here: Blueprint Medicines Corp's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation



Market Movers

Sponsored Financial Content